EUVIMEDEUVIMED entdecken
Kohortenstudie

Severe cutaneous adverse reactions and risk of autoimmune disease, including psoriasis and inflammatory bowel disease: a cohort study

Tzu-Min Lin, Yu-Sheng Chang, Yu-Chuan Shen, Hui-Ching Hsu, Wei-Sheng Chen, Hsiang-Yen Lee, Tzu-Tung Kuo, Shu-Chuan Chen, Jin-Hua Chen, Chi-Ching Chang iD

Clinical and Experimental Dermatology · 2025

DOI: 10.1093/ced/llaf344 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Clinical and Experimental Dermatology, 2025. Verfasst von Tzu-Min Lin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical Universit…. Hauptthemen laut MEDLINE: Autoimmune Diseases, Psoriasis, Inflammatory Bowel Diseases, Skin Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Limited evidence exists about the association between autoimmune disease risk and patients with severe cutaneous adverse reactions (SCARs).

Objectives

To estimate the risks of a set of incident autoimmune outcomes in patients with SCARs.

Methods

We used the Taiwan National Health Insurance Research Database to build a cohort of 21 170 eligible individuals with SCARs and a matched non-SCARs cohort comprising 211 700 individuals. We analysed the autoimmune outcomes of interest through a Cox proportional hazards model.

Results

During a mean follow-up period of 5.2 years (SD 2.6 years), 459 of 21 170 (2.2%) individuals with and 299 of 211 700 (0.1%) without SCARs developed incident autoimmune disease, respectively. The incidence rate of any autoimmune disease was 418.5 events per 100 000 person-years among patients with SCARs and 27.0 events per 100 000 person-years among those without SCARs and the adjusted hazard ratio of any autoimmune disease was 15.5 (95% confidence interval 13.4–17.9). Furthermore, there was increased risk of an array of incident autoimmune disease, including systemic vasculitis, type 1 diabetes mellitus, Henoch–Schönlein purpura, primary Sjögren syndrome, Addison disease, systemic lupus erythematosus, systemic sclerosis, inflammatory bowel disease (ulcerative colitis and Crohn disease), myasthenia gravis, Hashimoto thyroiditis, psoriasis, rheumatoid arthritis, ankylosing spondylitis, Graves disease and autoimmune haemolytic anaemia.

Conclusions

This study suggests that patients with SCARs have a higher risk of developing autoimmune diseases than patients without SCARs. Further research investigating the underlying mechanisms is warranted. Physicians should be attentive to potential sequelae that may arise following SCARs resolution during long-term follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autoimmune DiseasesPsoriasisInflammatory Bowel DiseasesSkin DiseasesHumansFemaleMaleMiddle AgedAdultTaiwanCohort StudiesIncidenceAgedProportional Hazards ModelsYoung AdultRisk FactorsAdolescent

Autor:innen und Institutionen

  • Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei City, Taiwan.
  • Division of Rheumatology, Immunology, and Allergy, Department of Internal Medicine, Taipei Medical University Hospital, Taipei City, Taiwan.
  • Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.
  • Division of Rheumatology, Immunology, and Allergy, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei City, Taiwan.
  • Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Taipei Veterans General Hospital, National Yang-Ming University, Taipei City, Taiwan.
  • Health Data Analytics and Statistics Center, Office of Data Science, Taipei Medical University, Taipei City, Taiwan.

ORCID-Profile: Chi-Ching Chang

Zitieren

APA

Lin, T. M., Chang, Y. S., Shen, Y. C., Hsu, H. C., Chen, W. S., Lee, H. Y., Kuo, T. T., Chen, S. C., Chen, J. H., & Chang, C. C. (2025). Severe cutaneous adverse reactions and risk of autoimmune disease, including psoriasis and inflammatory bowel disease: a cohort study. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llaf344

Vancouver

Lin TM, Chang YS, Shen YC, Hsu HC, Chen WS, Lee HY, et al. Severe cutaneous adverse reactions and risk of autoimmune disease, including psoriasis and inflammatory bowel disease: a cohort study. Clinical and Experimental Dermatology. 2025. doi:10.1093/ced/llaf344

BibTeX
@article{Lin2025,
  author = {Lin, Tzu-Min and Chang, Yu-Sheng and Shen, Yu-Chuan and Hsu, Hui-Ching and Chen, Wei-Sheng and Lee, Hsiang-Yen and Kuo, Tzu-Tung and Chen, Shu-Chuan and Chen, Jin-Hua and Chang, Chi-Ching},
  title = {Severe cutaneous adverse reactions and risk of autoimmune disease, including psoriasis and inflammatory bowel disease: a cohort study},
  journal = {Clinical and Experimental Dermatology},
  year = {2025},
  doi = {10.1093/ced/llaf344}
}
Kostenlos starten →